POST Online Media Lite Edition


Charles Reay Mackay to join Pfizer

Staff writer |
New York, N.Y., USA - March 31, 2015, New York, N.Y., USA - Pfizer Inc. announced that Charles Reay Mackay will join the company as chief scientific officer for Pfizer’s Inflammation and Immunology Research unit.

Article continues below

Professor Mackay will join Pfizer from Monash University in Australia, where he is a research fellow, and the Charles Perkins Center within the Faculty of Medicine at Sydney University, where he was Chair of Diabetes.

Professor Mackay has also held important biotech leadership positions at LeukoSite Inc. and Millennium Therapeutics in Cambridge, Massachusetts.


What to read next

Martin Mackay and Tony Zook to leave AstraZeneca
Pfizer appoints president of worldwide research and development
Charles M. Baum joins Array BioPharma board of directors